The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J., & Johnson, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011954 · Cited by 4,955
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
Chiller, J. O. H. S., Arrington, D. A. H., Elani, C. H. P. B., Anger, C., Andler, A. L. S., Rook, J. A. K., Hu, J., & Ohnson, D. A. H. J. (2002) · Cited by 3,730
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
Shaw, A. T., Kim, D.-W., Nakagawa, K., Seto, T., Crinó, L., Ahn, M.-J., De Pas, T., Besse, B., Solomon, B. J., Blackhall, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214886 · Cited by 3,381
Scagliotti, G. V., Parikh, P., von Pawel, J., Biesma, B., Vansteenkiste, J., Manegold, C., Serwatowski, P., Gatzemeier, U., Digumarti, R., Zukin, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0375 · Cited by 3,203
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Non-small Cell Lung Cancer Collaborative Group (1995) · BMJ · doi:10.1136/bmj.311.7010.899 · Cited by 2,850
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,171
DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
Olaussen, K. A., Dunant, A., Fouret, P., Brambilla, E., André, F., Haddad, V., Taranchon, E., Filipits, M., Pirker, R., Popper, H. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060570 · Cited by 1,727
Giaccone, G., Herbst, R. S., Manegold, C., Scagliotti, G., Rosell, R., Miller, V., Natale, R. B., Schiller, J. H., von Pawel, J., Pluzanska, A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.001 · Cited by 1,716
Herbst, R. S., Giaccone, G., Schiller, J. H., Natale, R. B., Miller, V., Manegold, C., Scagliotti, G., Rosell, R., Oliff, I., Reeves, J. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.215 · Cited by 1,707
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Bunting, S. F., Callén, E., Wong, N., Chen, H.-T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.012 · Cited by 1,671
Herbst, R. S., Prager, D., Hermann, R., Fehrenbacher, L., Johnson, B. E., Sandler, A., Kris, M. G., Tran, H. T., Klein, P., Li, X., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.840 · Cited by 1,490
Economic burden of cancer across the European Union: a population-based cost analysis
Luengo-Fernandez, R., Leal, J., Gray, A., & Sullivan, R. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70442-x · Cited by 1,008
Peters, S., Adjei, A. A., Gridelli, C., Reck, M., Kerr, K., & Felip, E. (2012) · Annals of Oncology · doi:10.1093/annonc/mds226 · Cited by 930
Azzoli, C. G., Baker, S., Temin, S., Pao, W., Aliff, T., Brahmer, J., Johnson, D. H., Laskin, J. L., Masters, G., Milton, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.5622 · Cited by 915
Gatzemeier, U., Pluzanska, A., Szczesna, A., Kaukel, E., Roubec, J., De Rosa, F., Milanowski, J., Karnicka-Mlodkowski, H., Pesek, M., Serwatowski, P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1474 · Cited by 881
Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA
Carpenter, D. (2014) · Princeton University Press eBooks · doi:10.1515/9781400835119 · Cited by 848
Hesketh, P. J., Grunberg, S. M., Gralla, R. J., Warr, D. G., Roila, F., de Wit, R., Chawla, S. P., Carides, A. D., Ianus, J., Elmer, M. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.095 · Cited by 779
Bertolini, G., Roz, L., Perego, P., Tortoreto, M., Fontanella, E., Gatti, L., Pratesi, G., Fabbri, A., Andriani, F., Tinelli, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905653106 · Cited by 767
Roila, F., Herrstedt, J., Aapro, M., Gralla, R. J., Einhorn, L. H., Ballatori, E., Bria, E., Clark-Snow, R. A., Espersen, B. T., Feyer, P., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq194 · Cited by 680
Reck, M., Popat, S., Reinmuth, N., De Ruysscher, D., Kerr, K. M., & Peters, S. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu199 · Cited by 679
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
Wolf, S., Barton, D., Kottschade, L., Grothey, A., & Loprinzi, C. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.04.018 · Cited by 632
Depierre, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.247 · Cited by 626
Ardizzoni, A., Boni, L., Tiseo, M., Fossella, F. V., Schiller, J. H., Paesmans, M., Radosavljevic, D., Paccagnella, A., Zatloukal, P., Mazzanti, P., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk196 · Cited by 612
New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials
Travis, W. D., Brambilla, E., & Riely, G. J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.9270 · Cited by 599
Platinum neurotoxicity pharmacogenetics
McWhinney, S. R., Goldberg, R. M., & McLeod, H. L. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0840 · Cited by 574
Quoix, E., Zalcman, G., Oster, J.-P., Westeel, V., Pichon, E., Lavolé, A., Dauba, J., Debieuvre, D., Souquet, P.-J., Bigay-Game, L., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60780-0 · Cited by 566
Knight, K. R. G., Kraemer, D. F., & Neuwelt, E. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5355 · Cited by 542
The Discovery and Development of Cisplatin
Alderden, R. A., Hall, M. D., & Hambley, T. W. (2006) · Journal of Chemical Education · doi:10.1021/ed083p728 · Cited by 532
Reputation and power: organizational image and pharmaceutical regulation at the FDA
(2011) · Choice Reviews Online · doi:10.5860/choice.48-3548 · Cited by 524
Treatment of testicular cancer: a new and improved model.
Einhorn, L. H. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.11.1777 · Cited by 504
Genetic heterogeneity and cancer drug resistance
Turner, N. C., & Reis-Filho, J. S. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70335-7 · Cited by 454
Lynch, T. J., Patel, T., Dreisbach, L., McCleod, M., Heim, W. J., Hermann, R. C., Paschold, E., Iannotti, N. O., Dakhil, S., Gorton, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9618 · Cited by 447
Scagliotti, G., Novello, S., von Pawel, J., Reck, M., Pereira, J. R., Thomas, M., Abrão Miziara, J. E., Balint, B., De Marinis, F., Keller, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.1321 · Cited by 447
Cullen, M. H., Billingham, L. J., Woodroffe, C. M., Chetiyawardana, A. D., Gower, N. H., Joshi, R., Ferry, D. R., Rudd, R. M., Spiro, S. G., Cook, J. E., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3188 · Cited by 445
Self-citationChemotherapy, chemoresistance and the changing treatment landscape for NSCLC
Chang, A. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2010.08.022 · Cited by 443
Wood, A. J. J., & Ihde, D. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272006 · Cited by 428
Kumar, & Abbas (2016) · Cited by 409
Marty, M., Pouillart, P., Scholl, S., Droz, J. P., Azab, M., Brion, N., Pujade-Lauraine, E., Paule, B., Paes, D., & Bons, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003223221205 · Cited by 406
Kumar, V., Abbas, A. K., & Aster, J. C. (2022) · Robbins Basic Pathology · doi:10.33029/9704-6467-0-krb-2022-1-1036 · Cited by 371
ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer
Friboulet, L., Olaussen, K. A., Pignon, J.-P., Shepherd, F. A., Tsao, M.-S., Graziano, S., Kratzke, R., Douillard, J.-Y., Seymour, L., Pirker, R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214271 · Cited by 371
Sherman-Baust, C. A., Weeraratna, A. T., Rangel, L. B. A., Pizer, E. S., Cho, K. R., Schwartz, D. R., Shock, T., & Morin, P. J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00058-8 · Cited by 339
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
Ruckdeschel, J. C., Finkelstein, D. M., Ettinger, D. S., Creech, R. H., Mason, B. A., Joss, R., & Vogl, S. E. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.1.14 · Cited by 338
Bonomi, P. D., Finkelstein, D. M., Ruckdeschel, J. C., Blum, R. H., Green, M. D., Mason, B., Hahn, R., Tormey, D. C., Harris, J., & Comis, R. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.11.1602 · Cited by 323
Drummond, J. T., Anthoney, A., Brown, R., & Modrich, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19645 · Cited by 295
Azzoli, C. G., Temin, S., Aliff, T., Baker, S., Brahmer, J., Johnson, D. H., Laskin, J. L., Masters, G., Milton, D., Nordquist, L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.2774 · Cited by 285
Barr, M. P., Gray, S. G., Hoffmann, A. C., Hilger, R. A., Thomale, J., O’Flaherty, J. D., Fennell, D. A., Richard, D., O’Leary, J. J., & O’Byrne, K. J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233739 · Cited by 269
Self-citationImprovement of Cis-dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal model
Cvitkovic, E., Spaulding, J., Bethune, V., Martin, J., & Whitmore, W. F. (1977) · Cancer · doi:10.1002/1097-0142(197704)39:4<1357::aid-cncr2820390402>3.0.co;2-c · Cited by 259
DNA Damage Triggers Golgi Dispersal via DNA-PK and GOLPH3
Farber-Katz, S. E., Dippold, H. C., Buschman, M. D., Peterman, M. C., Xing, M., Noakes, C. J., Tat, J., Ng, M. M., Rahajeng, J., Cowan, D. M., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.023 · Cited by 257
Vascular toxicity associated with antineoplastic agents.
Doll, D. C., Ringenberg, Q. S., & Yarbro, J. W. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.9.1405 · Cited by 250
Paz-Ares, L. G., Biesma, B., Heigener, D. F., von Pawel, J., Eisen, T., Bennouna, J., Zhang, L., Liao, M., Sun, Y., Gans, S. J. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7646 · Cited by 250
Zukin, M., Barrios, C. H., Rodrigues Pereira, J., De Albuquerque Ribeiro, R., de Mendonça Beato, C. A., do Nascimento, Y. N., Murad, A., Franke, F. A., Precivale, M., de Lima Araujo, L. H., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.1911 · Cited by 235
Heymach, J. V., Paz-Ares, L., De Braud, F., Sebastian, M., Stewart, D. J., Eberhardt, W. E. E., Ranade, A. A., Cohen, G., Trigo, J. M., Sandler, A. B., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.3138 · Cited by 222
Rajeswaran, A., Trojan, A., Burnand, B., & Giannelli, M. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2007.07.012 · Cited by 221
Grunberg, S., Chua, D., Maru, A., Dinis, J., DeVandry, S., Boice, J. A., Hardwick, J. S., Beckford, E., Taylor, A., Carides, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.7859 · Cited by 217
Mok, T. S. K., Wu, Y.-L., Yu, C.-J., Zhou, C., Chen, Y.-M., Zhang, L., Ignacio, J., Liao, M., Srimuninnimit, V., Boyer, M. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.5541 · Cited by 216
Phase III Study of Matrix Metalloproteinase Inhibitor Prinomastat in Non–Small-Cell Lung Cancer
Bissett, D., O’Byrne, K. J., von Pawel, J., Gatzemeier, U., Price, A., Nicolson, M., Mercier, R., Mazabel, E., Penning, C., Zhang, M. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.170 · Cited by 209
BRCA1 mRNA Expression Levels Predict for Overall Survival in Ovarian Cancer after Chemotherapy
Quinn, J. E., James, C. R., Stewart, G. E., Mulligan, J. M., White, P., Chang, G. K. F., Mullan, P. B., Johnston, P. G., Wilson, R. H., & Harkin, D. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1083 · Cited by 207
Numico, G., Garrone, O., Dongiovanni, V., Silvestris, N., Colantonio, I., Di Costanzo, G., Granetto, C., Occelli, M., Fea, E., Heouaine, A., et al. (2005) · Cancer · doi:10.1002/cncr.20893 · Cited by 197
Holford, J., Sharp, S. Y., Murrer, B. A., Abrams, M., & Kèlland, L. R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.59 · Cited by 197
Edelman, M. J., Watson, D., Wang, X., Morrison, C., Kratzke, R. A., Jewell, S., Hodgson, L., Mauer, A. M., Gajra, A., Masters, G. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8081 · Cited by 194
Leighl, N. B., Paz-Ares, L., Douillard, J.-Y., Peschel, C., Arnold, A., Depierre, A., Santoro, A., Betticher, D. C., Gatzemeier, U., Jassem, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.044 · Cited by 179
Langer, C. J., Novello, S., Park, K., Krzakowski, M., Karp, D. D., Mok, T., Benner, R. J., Scranton, J. R., Olszanski, A. J., & Jassem, J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.4932 · Cited by 179
Cisplatin Resistance Associated with PARP Hyperactivation
Michels, J., Vitale, I., Galluzzi, L., Adam, J., Olaussen, K. A., Kepp, O., Senovilla, L., Talhaoui, I., Guegan, J., Enot, D. P., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3000 · Cited by 176
Relationship Between Cisplatin Administration and the Development of Ototoxicity
Rademaker-Lakhai, J. M., Crul, M., Zuur, L. C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.077 · Cited by 176
Manegold, C., Gravenor, D., Woytowitz, D., Mezger, J., Hirsh, V., Albert, G., Al-Adhami, M., Readett, D., Krieg, A. M., & Leichman, C. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.5807 · Cited by 171
Ueber die Einwirkung des Ammoniaks auf Platinchlorür
Peyrone, M. (1844) · Justus Liebigs Annalen der Chemie · doi:10.1002/jlac.18440510102 · Cited by 168
Gridelli, C., Ardizzoni, A., Le Chevalier, T., Manegold, C., Perrone, F., Thatcher, N., van Zandwijk, N., Di Maio, M., Martelli, O., & De Marinis, F. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh087 · Cited by 164
Paz-Ares, L. G., Douillard, J., Koralewski, P., Manegold, C., Smit, E. F., Reyes, J. M., Chang, G., John, W. J., Peterson, P. M., Obasaju, C. K., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3299 · Cited by 154
Thongprasert, S. (1999) · Lung Cancer · doi:10.1016/s0169-5002(99)00017-3 · Cited by 151
Hirsh, V., Paz-Ares, L. G., Boyer, M. J., Rosell, R., Middleton, G., Eberhardt, W., Szczęsna, A., Reiterer, P., Saleh, M. N., Arrieta, O. G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.8971 · Cited by 141
Helsing, M., Bergman, B., Thaning, L., & Hero, U. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10122-8 · Cited by 132
Travis, L. B., Fosså, S. D., Sesso, H. D., Frisina, R. D., Herrmann, D. N., Beard, C. J., Feldman, D. R., Pagliaro, L. C., Miller, R. C., Vaughn, D. J., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju044 · Cited by 123
Shin, D. H., Choi, Y., & Park, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2620 · Cited by 115
Distinct Mechanisms for Ctr1-mediated Copper and Cisplatin Transport
Sinani, D., Adle, D. J., Kim, H., & Lee, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703973200 · Cited by 113
Lechner, D., Kollars, M., Gleiß, A., Kyrle, P. A., & Weltermann, A. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02788.x · Cited by 113
Park, J., Morley, T. S., & Scherer, P. E. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202006 · Cited by 112
Rossi, A., Chiodini, P., Sun, J., O'Brien, M. E. R., von Plessen, C., Barata, F. J., Park, K., Popat, S., Bergman, B., Parente, B., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70402-4 · Cited by 111
Groen, H. J. M., Sietsma, H., Vincent, A. D., Hochstenbag, M. M. H., van Putten, J. W. G., van den Berg, A., Dalesio, O., Biesma, B., Smit, H. J. M., Termeer, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5214 · Cited by 111
Novel Concepts in the Development of Platinum Antitumor Drugs
Fuertes, M. A., Castilla, J., Alonso, C., & Perez, J. (2002) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011023353958 · Cited by 105
Laurie, S. A., Solomon, B., Seymour, L., Ellis, P. M., Goss, G. D., Shepherd, F. A., Boyer, M. J., Arnold, A., Clingan, P. R., Laberge, F., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.11.032 · Cited by 101
Katayama, H. G., Wang, J., Treekitkarnmongkol, W., Kawai, H., Sasai, K., Zhang, H., Wang, H., Adams, H. P., Jiang, S., Chakraborty, S. N., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.025 · Cited by 91
Shukuya, T., Yamanaka, T., Seto, T., Daga, H., Goto, K., Saka, H., Sugawara, S., Takahashi, T., Yokota, S., Kaneda, H., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00305-8 · Cited by 90
Weick, J. K., Crowley, J. J., Natale, R. B., Hom, B. L., Rivkin, S. E., Coltman, C. A., Taylor, S. A., & Livingston, R. B. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1157 · Cited by 90
Ramlau, R., Zatloukal, P., Jassem, J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2614 · Cited by 89
Ueda, K., Kawashima, H., Ohtani, S., Deng, W., Ravoori, M. K., Bankson, J. A., Gao, B., Girard, L., Minna, J. D., Roth, J. A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1483 · Cited by 76
Lee, S. M., Rudd, R., Woll, P. J., Ottensmeier, C. H. H., Gilligan, D., Price, A., Spiro, S. G., Gower, N. H., Jitlal, M., & Hackshaw, A. K. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9733 · Cited by 76
Lilenbaum, R., Villaflor, V. M., Langer, C. J., O'Byrne, K. J., O'Brien, M. E. R., Ross, H. J., Socinski, M. A., Oldham, F. B., Sandilac, L., Singer, J. W., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a9a020 · Cited by 72
Papadaki, C., Sfakianaki, M., Ioannidis, G., Lagoudaki, E. D., Trypaki, M., Tryfonidis, K., Mavroudis, D., Stathopoulos, E. N., Georgoulias, V., & Souglakos, J. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318244bdd4 · Cited by 69
Horinouchi, H., Kubota, K., Itani, H., Taniyama, T. K., Nakamichi, S., Wakui, H., Kanda, S., Nokihara, H., Yamamoto, N., Sekine, I., et al. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt122 · Cited by 63
Muraki, K., Koyama, R., Honma, Y., Yagishita, S., Shukuya, T., Ohashi, R., Takahashi, F., Kido, K., Iwakami, S., Sasaki, S., et al. (2012) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2012.10.16 · Cited by 62
Detection of Impaired Homologous Recombination Repair in NSCLC Cells and Tissues
Birkelbach, M. A., Ferraiolo, N., Gheorghiu, L., Pfäffle, H. N., Daly, B. D. T., Ebright, M. I., Spencer, C., O’Hara, C., Whetstine, J. R., Benes, C. H., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31827ecf83 · Cited by 59
PARP1 impact on DNA repair of platinum adducts: Preclinical and clinical read-outs
Olaussen, K. A., Adam, J., Vanhecke, E., Vielh, P. R., Pirker, R., Friboulet, L., Popper, H., Robin, A., Commo, F., Thomale, J., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.01.014 · Cited by 51
Marsit, C. J., Hasegawa, M., Hirao, T., Kim, D., Aldape, K., Hinds, P. W., Wiencke, J. K., Nelson, H. H., & Kelsey, K. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2558 · Cited by 50
NCCN Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network.
Demetri, G. D., ELIAS, A. D., Gershenson, D. M., Fossella, F. V., Grecula, J. C., Mittal, B. B., Raschko, J. W., & Robertson, J. (1996) · PubMed · Cited by 49
Lee, S. Y., Kang, H., Yoo, S. S., Kang, Y. E., Choi, Y. Y., Lee, W. K., Choi, J. E., Jeon, H., Shin, K. M., Oh, I., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.07.024 · Cited by 47
Dy, G. K., Mandrekar, S. J., Nelson, G. D., Meyers, J. P., Adjei, A. A., Ross, H. J., Ansari, R., Lyss, A. P., Stella, P. J., Schild, S. E., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318274a85d · Cited by 44
Ridolfi, L. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1099 · Cited by 40
Paul, I., Savage, K. I., Blayney, J. K., Lamers, E., Gately, K. A., Kerr, K. M., Sheaff, M. T., Arthur, K., Richard, D. J., Hamilton, P. W., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2925 · Cited by 35
Self-citationPlatinum rechallenge in patients with advanced NSCLC: A pooled analysis
Petrelli, F., Coinu, A., Cabiddu, M., Ghilardi, M., Ardine, M., & Barni, S. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.06.022 · Cited by 35
Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation
Takigawa, N., Ochi, N., Yamane, H., Hotta, K., Fujii, H., Isozaki, H., Honda, Y., Yamagishi, T., Kubo, T., Tanimoto, M., et al. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s71419 · Cited by 27
Bonanno, L., Costa, C., Majem, M., Sánchez, J. J., Giménez-Capitán, A. A., Rodríguez, I., Vergnenégre, A., Massutí, B., Favaretto, A. G., Rugge, M., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1157 · Cited by 26
Blumenschein, G. R., Ludwig, C., Thomas, G., Tan, E., Fanucchi, M., Santoro, A., Crawford, J., Breton, J. L., O’Brien, M., & Khuri, F. R. (2005) · Lung Cancer · doi:10.1016/s0169-5002(05)80215-6 · Cited by 24
19q13-ERCC1 Gene Copy Number Increase in Non–Small-Cell Lung Cancer
Vanhecke, E., Valent, A., Tang, X., Vielh, P. R., Friboulet, L., Tang, T., Goubar, A., Li, Y., Robin, A., Behrens, C., et al. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.01.006 · Cited by 12
Cited by
3D-3-culture: a tool to unveil macrophage plasticity in the tumour microenvironment
Rebelo, S. P., Pinto, C., Martins, T. R., Harrer, N., Estrada, M. F., Loza-Alvarez, P., Cabeçadas, J., Alves, P. M., Gualda, E. J., Sommergruber, W., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.030 · Cited by 227
Jacobi, N., Seeboeck, R., Hofmann, E., Schweiger, H., Smolinska, V., Mohr, T., Boyer, A., Sommergruber, W., Lechner, P., Pichler-Huebschmann, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22475 · Cited by 43
Metadata
- Authors
- Fennell, D. A., Summers, Y., Cadranel, J., Benepal, T., Christoph, D. C., Lal, R., Das, M., Maxwell, F., Visseren-Grul, C., & Ferry, D.
- Venue
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Published
- 2016-03
- Volume
- 44
- Pages
- 42-50
- ISSN
- 0305-7372 (ISSN-L)
- OpenAlex
- W2259656061
- Cited by
- 382
- References
- 109
- FWCI
- 29.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
